Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients

Autor: Florentino Villanego, Auxiliadora Mazuecos, Beatriz Cubillo, M José Merino, Inmaculada Poveda, Isabel M Saura, Óscar Segurado, Leónidas Cruzado, Myriam Eady, Sofía Zárraga, M José Aladrén, Sheila Cabello, Verónica López, Esther González, Inmaculada Lorenzo, Jordi Espí-Reig, Constantino Fernández, July Osma, M Carmen Ruiz-Fuentes, Néstor Toapanta, Antonio Franco, Carla C Burballa, Miguel A Muñoz, Marta Crespo, Julio Pascual

Publikováno v: CLINICAL KIDNEY JOURNAL
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Scientia
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe

Background Sotrovimab is a neutralizing monoclonal antibody (mAb) that seems to remain active against recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The evidence on its use in kidney transplant (KT) recipients, however,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c749f5be907769a8ffeb4f926cde3fe
https://fundanet.fisabio.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=13874

Screening for tropical and imported infections in migrant kidney transplant candidates from the kidney transplant access consultation.

Autor: Pedreira-Robles G; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; ESIMar (Escuela Superior de Enfermería del Mar), Parc de Salut Mar, Centro adscrito a la Universitat Pompeu Fabra, Barcelona, Spain; SDHEd (Grupo de Investigación en Determinantes Sociales y Educación en Salud), IMIM (Instituto Hospital del Mar de Investigaciones Médicas), Barcelona, Spain., Bach-Pascual A; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain., Collado-Nieto S; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain., Padilla E; Laboratorio de Referencia de Catalunya, Barcelona, Spain., Burballa C; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain., Arias-Cabrales C; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain., Redondo-Pachón D; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain., Sánchez F; Servicio de Enfermedades Infecciosas, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Universitat Pompeu Fabra, Hospital del Mar, Barcelona, Spain., Horcajada JP; Servicio de Enfermedades Infecciosas, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Universitat Pompeu Fabra, Hospital del Mar, Barcelona, Spain., Pascual J; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain; Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, Spain., Crespo M; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain., Villar-García J; Servicio de Enfermedades Infecciosas, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), Universitat Pompeu Fabra, Hospital del Mar, Barcelona, Spain., Pérez-Sáez MJ; Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain. Electronic address: mperezsaez@psmar.cat.

Publikováno v: Nefrologia [Nefrologia (Engl Ed)] 2024 Jul-Aug; Vol. 44 (4), pp. 549-559. Date of Electronic Publication: 2024 Jul 29.

Dynamics of HLA and angiotensin II type 1 receptor antibodies during pregnancy.

Autor: Burballa C; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Llinàs-Mallol L; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Vázquez S; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Pérez-Sáez MJ; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Arias-Cabrales C; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Buxeda A; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Hernandez JL; Department of Obstetrics and Gynecology, Hospital del Mar, Barcelona, Spain., Riera M; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Sanz S; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Alari-Pahissa E; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Federico-Vega J; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Eguía J; Laboratori de Referència de Catalunya SA, Barcelona, Spain., Pascual J; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Department of Nephrology, Hospital 12 de Octubre, Madrid, Spain., Redondo-Pachón D; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Crespo M; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Nephropathies Research Group, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. Electronic address: mcrespo@psmar.cat.

Publikováno v: Human immunology [Hum Immunol] 2024 Mar; Vol. 85 (2), pp. 110749. Date of Electronic Publication: 2024 Jan 18.

Clinical and genetic characteristics of Dent's disease type 1 in Europe.

Autor: Burballa C; Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain., Cantero-Recasens G; Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain., Prikhodina L; Veltishev Research and Clinical Institute for Pediatrics, Pirogov Russian National Research Medical University, Moscow, Russia., Lugani F; IRCCS Istituto G. Gaslini, Genova, Italy., Schlingmann K; University Children's Hospital, Münster, Germany., Ananin PV; Scientific Centre of Children Health 2, Moscow, Russia., Besouw M; University Medical Center, Groningen, The Netherlands., Bockenhauer D; UCL Division of Medicine and Great Ormond Street Hospital, London, UK., Madariaga L; Hospital Universitario Cruces, Biocruces-Bizkaia, UPV/EHU, Barakaldo, Spain., Bertholet-Thomas A; Hopital Femme Mere Enfant, Lyon, France., Taroni F; Pediatric Nephrology Dialysis and Transplant Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy., Parolin M; Nefrologia Pediatrica, Dialisi e Trapianto, Università di Padova, Padova, Italy., Conlon P; Beaumont Hospital, Dublin, Ireland., Emma F; Division of Nephrology, Bambino Gesú Children's Hospital-IRCCS, Rome, Italy., Del Prete D; Azienda Ospedale-Universita, Padova, Italy., Chauveau D; Hopital Rangueil, Toulouse, France., Koster-Kamphuis L; Amalia Children's Hospital, Radboud University Medical Center, Nijmegen, The Netherlands., Fila M; Hôpital Arnaud de Villeneuve, Pédiatrie Service, Montpellier, France., Pasini A; Azienda Ospedaliero-Universitaria Santorsola-Malpighi Bologna, Italy., Castro I; Complexo Hospitalario de Pontevedra, Pontevedra, Spain., Colussi G; Niguarda Hospital, Milan, Italy., Gil M; Hospital Universitario Santiago de Compostela, Santiago de Compostela, Spain., Mohidin B; Royal Free Hospital, London, UK., Wlodkowski T; Heidelberg University Hospital, Heidelberg, Germany., Schaefer F; Heidelberg University Hospital, Heidelberg, Germany., Ariceta G; Vall d'Hebron University Hospital, Vall d'Hebron Research Institute, Barcelona, Spain.

Publikováno v: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Nephrol Dial Transplant] 2023 May 31; Vol. 38 (6), pp. 1497-1507.

Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration.

Autor: Buxeda A; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Llinàs-Mallol L; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Gimeno J; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Department of Pathology, Hospital del Mar, Barcelona, Spain., Redondo-Pachón D; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Arias-Cabrales C; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Burballa C; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Puche A; Department of Pathology, Hospital del Mar, Barcelona, Spain., López-Botet M; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain., Yélamos J; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Department of Immunology, Hospital del Mar, Barcelona, Spain., Vilches C; Immunogenetics-HLA, Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana, Majadahonda, Madrid, Spain., Naesens M; Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium., Pérez-Sáez MJ; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Pascual J; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain; Department of Nephrology, Hospital Universitario 12 de Octubre, Madrid, Spain., Crespo M; Department of Nephrology, Hospital del Mar, Barcelona, Spain; Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain. Electronic address: mcrespo@psmar.cat.

Publikováno v: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2023 Apr; Vol. 23 (4), pp. 464-474. Date of Electronic Publication: 2023 Jan 03.